Fresenius SE Current Ratio 2016-2023 | FSNUY

Current and historical current ratio for Fresenius SE (FSNUY) from 2016 to 2023. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Fresenius SE current ratio for the three months ending September 30, 2023 was 1.54.
Fresenius SE Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2023-09-30 $48.80B $31.77B 1.54
2023-06-30 $21.05B $17.51B 1.20
2023-03-31 $20.50B $17.09B 1.20
2022-12-31 $19.26B $14.39B 1.34
2022-09-30 $19.58B $14.97B 1.31
2022-06-30 $20.03B $15.22B 1.32
2022-03-31 $20.20B $0.39B 52.03
2021-12-31 $20.66B $17.82B 1.16
2021-09-30 $20.44B $18.10B 1.13
2021-06-30 $20.36B $18.32B 1.11
2021-03-31 $20.13B $19.23B 1.05
2020-12-31 $18.02B $15.10B 1.19
2020-09-30 $19.68B $16.20B 1.22
2020-06-30 $18.89B $17.00B 1.11
2020-03-31 $18.03B $17.64B 1.02
2019-12-31 $17.10B $15.55B 1.10
2019-09-30 $16.88B $15.32B 1.10
2019-06-30 $16.69B $15.45B 1.08
2019-03-31 $16.99B $15.53B 1.09
2018-12-31 $17.47B $15.68B 1.11
2018-09-30 $16.97B $15.46B 1.10
2018-06-30 $17.04B $14.46B 1.18
2018-03-31 $16.48B $13.83B 1.19
2017-12-31 $14.25B $12.06B 1.18
2017-09-30 $15.13B $12.51B 1.21
2017-06-30 $14.08B $11.41B 1.23
2017-03-31 $13.94B $10.85B 1.28
2016-12-31 $13.06B $9.46B 1.38
2016-09-30 $12.32B $9.35B 1.32
2016-06-30 $12.43B $9.10B 1.37
2016-03-31 $11.68B $8.16B 1.43
2015-12-31 $12.12B $8.23B 1.47
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $17.827B $24.011B
Fresenius SE & Co is a health care company. It offers products and services for dialysis, hospitals and outpatient treatment. The company's business segment consists of Fresenius Medical Care is engaged in treating with chronic kidney failure; Fresenius Helios is a hospital operator; Fresenius Kabi supplies essential drugs, clinical nutrition products, medical devices and services and Fresenius Vamed plans, develops and manages healthcare facilities. Fresenius SE & Co is headquartered in Bad Homburg, Germany.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $15.637B 16.16
DaVita (DVA) United States $12.266B 15.23
Elanco Animal Health (ELAN) United States $9.068B 23.53
Encompass Health (EHC) United States $8.515B 21.80
Chemed (CHE) United States $8.153B 25.27
Option Care Health (OPCH) United States $4.910B 18.59
RadNet (RDNT) United States $4.516B 94.05
Amedisys (AMED) United States $3.000B 21.25
Astrana Health (ASTH) United States $2.226B 30.11
LifeStance Health (LFST) United States $2.018B 0.00
Addus HomeCare (ADUS) United States $1.932B 27.64
U.S Physical Therapy (USPH) United States $1.433B 38.36
Pennant (PNTG) United States $0.697B 36.81
Aveanna Healthcare Holdings (AVAH) United States $0.483B 0.00
Atai Life Sciences (ATAI) Germany $0.221B 0.00
Daxor (DXR) United States $0.043B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.025B 0.00
ATI Physical Therapy (ATIP) United States $0.019B 0.00
Novo Integrated Sciences (NVOS) United States $0.018B 0.00
Psychemedics (PMD) United States $0.013B 0.00
Ontrak (OTRK) United States $0.012B 0.00
IMAC Holdings (BACK) United States $0.003B 0.00